Specifically, we found EPS8, DSG2, RHOD, ITGB6, ANKRD37, SELENBP1, FOXA3, and ALDH1A1 could be potential biomarkers to accurately predict the prognosis of pancreatic cancer patients. This evidence concerns the gene DSG2 and familial pancreatic carcinoma.